[fusion_builder_container type="flex" hundred_percent="no" equal_height_columns="no" hide_on_mobile="small-visibility,medium-visibility,large-visibility" background_position="center center" background_repeat="no-repeat" fade="no" background_parallax="none" parallax_speed="0.3" video_aspect_ratio="16:9" video_loop="yes" video_mute="yes" border_style="solid"][fusion_builder_row][fusion_builder_column type="1_1" type="1_1" layout="1_1" background_position="left top" border_style="solid" border_position="all" spacing="yes" background_repeat="no-repeat" margin_top="0px" margin_bottom="0px" animation_speed="0.3" animation_direction="left" hide_on_mobile="small-visibility,medium-visibility,large-visibility" center_content="no" last="true" hover_type="none" background_blend_mode="overlay" first="true" min_height="" link=""][fusion_text]<span style="background-color: var(--awb-bg-color); color: var(--h3_typography-color); font-family: var(--h3_typography-font-family); font-size: var(--h3_typography-font-size); font-style: var(--h3_typography-font-style,normal); font-weight: var(--h3_typography-font-weight); letter-spacing: var(--h3_typography-letter-spacing); text-align: var(--awb-content-alignment); text-transform: var(--h3_typography-text-transform);">Food Allergies Treatment of Multi-Food Allergy with Omalizumab Compared to Omalizumab-Facilitated Multi-Allergen OIT Recognize and Respond to Anaphylaxis <a style="font-family: var(--awb-text-font-family); font-size: var(--awb-font-size); font-style: var(--awb-text-font-style); font-weight: var(--awb-text-font-weight); letter-spacing: var(--awb-letter-spacing); text-align: var(--awb-content-alignment); text-transform: var(--awb-text-transform); background-color: var(--awb-bg-color);" href="https://www.foodallergy.org/living-food-allergies/food-allergy-essentials/free-downloadable-resources" target="_blank" rel="noopener noreferrer">FARE (Food Allergy Research & Education) Resources <a style="font-family: var(--awb-text-font-family); font-size: var(--awb-font-size); font-style: var(--awb-text-font-style); font-weight: var(--awb-text-font-weight); letter-spacing: var(--awb-letter-spacing); text-align: var(--awb-content-alignment); text-transform: var(--awb-text-transform); background-color: var(--awb-bg-color);" href="https://www.foodallergy.org/living-food-allergies/food-allergy-essentials/common-allergens" target="_blank" rel="noopener noreferrer">Common Allergens <a style="font-family: var(--awb-text-font-family); font-size: var(--awb-font-size); font-style: var(--awb-text-font-style); font-weight: var(--awb-text-font-weight); letter-spacing: var(--awb-letter-spacing); text-align: var(--awb-content-alignment); text-transform: var(--awb-text-transform); background-color: var(--awb-bg-color);" href="https://m2.healio.com/~/media/vme-educational-tools/allergy/fare_understandingfoodlabels.pdf" target="_blank" rel="noopener noreferrer">Understanding Food Labels <a style="font-family: var(--awb-text-font-family); font-size: var(--awb-font-size); font-style: var(--awb-text-font-style); font-weight: var(--awb-text-font-weight); letter-spacing: var(--awb-letter-spacing); text-align: var(--awb-content-alignment); text-transform: var(--awb-text-transform); background-color: var(--awb-bg-color);" href="https://www.youtube.com/watch?v=aYNQPBtOjiE" target="_blank" rel="noopener noreferrer">It's a Disease, Not a Diet: A documentary about life with food allergies <a style="font-family: var(--awb-text-font-family); font-size: var(--awb-font-size); font-style: var(--awb-text-font-style); font-weight: var(--awb-text-font-weight); letter-spacing: var(--awb-letter-spacing); text-align: var(--awb-content-alignment); text-transform: var(--awb-text-transform); background-color: var(--awb-bg-color);" href="https://www.foodallergy.org/living-food-allergies/information-you/children-food-allergies" target="_blank" rel="noopener noreferrer">Children With Food Allergies <a style="font-family: var(--awb-text-font-family); font-size: var(--awb-font-size); font-style: var(--awb-text-font-style); font-weight: var(--awb-text-font-weight); letter-spacing: var(--awb-letter-spacing); text-align: var(--awb-content-alignment); text-transform: var(--awb-text-transform); background-color: var(--awb-bg-color);" href="https://www.foodallergy.org/resources/preparing-college" target="_blank" rel="noopener noreferrer">Living with Food Allergies: Preparing for College <a style="font-family: var(--awb-text-font-family); font-size: var(--awb-font-size); font-style: var(--awb-text-font-style); font-weight: var(--awb-text-font-weight); letter-spacing: var(--awb-letter-spacing); text-align: var(--awb-content-alignment); text-transform: var(--awb-text-transform); background-color: var(--awb-bg-color);" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2312382#ap0" target="_blank" rel="noopener noreferrer">Omalizumab for the Treatment of Multiple Food Allergies <a style="font-family: var(--awb-text-font-family); font-size: var(--awb-font-size); font-style: var(--awb-text-font-style); font-weight: var(--awb-text-font-weight); letter-spacing: var(--awb-letter-spacing); text-align: var(--awb-content-alignment); text-transform: var(--awb-text-transform); background-color: var(--awb-bg-color);" href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/103976s5245lbl.pdf" target="_blank" rel="noopener noreferrer">Omalizumab Prescribing Information <a style="font-family: var(--awb-text-font-family); font-size: var(--awb-font-size); font-style: var(--awb-text-font-style); font-weight: var(--awb-text-font-weight); letter-spacing: var(--awb-letter-spacing); text-align: var(--awb-content-alignment); text-transform: var(--awb-text-transform); background-color: var(--awb-bg-color);" href="https://www.fda.gov/media/134838/download" target="_blank" rel="noopener noreferrer">Peanut Oral Immunotherapy Prescribing Information <a style="font-family: var(--awb-text-font-family); font-size: var(--awb-font-size); font-style: var(--awb-text-font-style); font-weight: var(--awb-text-font-weight); letter-spacing: var(--awb-letter-spacing); text-align: var(--awb-content-alignment); text-transform: var(--awb-text-transform); background-color: var(--awb-bg-color);" href="https://m4.healio.com/~/media/vme-educational-tools/allergy/warren-et-al-2024-waoj.pdf" target="_blank" rel="noopener noreferrer">Clinical Burden of Food Allergies: Insights from the FARE Patient Registry <a style="font-family: var(--awb-text-font-family); font-size: var(--awb-font-size); font-style: var(--awb-text-font-style); font-weight: var(--awb-text-font-weight); letter-spacing: var(--awb-letter-spacing); text-align: var(--awb-content-alignment); text-transform: var(--awb-text-transform); background-color: var(--awb-bg-color);" href="https://m2.healio.com/~/media/vme-educational-tools/allergy/casale-et-al-2024-waoj.pdf" target="_blank" rel="noopener noreferrer">Mental Health Burden of Food Allergies: Insights from Patients and Their Caregivers from FARE Patient Registry <a style="font-family: var(--awb-text-font-family); font-size: var(--awb-font-size); font-style: var(--awb-text-font-style); font-weight: var(--awb-text-font-weight); letter-spacing: var(--awb-letter-spacing); text-align: var(--awb-content-alignment); text-transform: var(--awb-text-transform); background-color: var(--awb-bg-color);" href="https://www.niaid.nih.gov/diseases-conditions/food-allergy" target="_blank" rel="noopener noreferrer">Food Allergies: National Institute of Allergy and Infectious Diseases <a style="font-family: var(--awb-text-font-family); font-size: var(--awb-font-size); font-style: var(--awb-text-font-style); font-weight: var(--awb-text-font-weight); letter-spacing: var(--awb-letter-spacing); text-align: var(--awb-content-alignment); text-transform: var(--awb-text-transform); background-color: var(--awb-bg-color);" href="https://acaai.org/allergies/allergic-conditions/food/" target="_blank" rel="noopener noreferrer">Food Allergy Information from the American College of Allergy, Asthma & Immunology <a style="font-family: var(--awb-text-font-family); font-size: var(--awb-font-size); font-style: var(--awb-text-font-style); font-weight: var(--awb-text-font-weight); letter-spacing: var(--awb-letter-spacing); text-align: var(--awb-content-alignment); text-transform: var(--awb-text-transform); background-color: var(--awb-bg-color);" href="https://kidswithfoodallergies.org/" target="_blank" rel="noopener noreferrer">Kids With Food Allergies <a style="font-family: var(--awb-text-font-family); font-size: var(--awb-font-size); font-style: var(--awb-text-font-style); font-weight: var(--awb-text-font-weight); letter-spacing: var(--awb-letter-spacing); text-align: var(--awb-content-alignment); text-transform: var(--awb-text-transform); background-color: var(--awb-bg-color);" href="https://www.foodallergy.org/making-healthy-eating-easy-everyone" target="_blank" rel="noopener noreferrer">FARE powered by Sifter Shopping Tool for Food Allergy Needs <a style="font-family: var(--body_typography-font-family); font-size: var(--body_typography-font-size); font-style: var(--body_typography-font-style,normal); font-weight: var(--body_typography-font-weight); letter-spacing: var(--body_typography-letter-spacing); text-align: var(--awb-content-alignment); text-transform: var(--awb-text-transform); background-color: rgba(255, 255, 255, 0);" href="https://onlinelibrary.wiley.com/doi/epdf/10.1111/all.15418" target="_blank" rel="noopener noreferrer">Food allergy, mechanisms, diagnosis and treatment: Innovation through a multi-targeted approach <a style="font-family: var(--body_typography-font-family); font-size: var(--body_typography-font-size); font-style: var(--body_typography-font-style,normal); font-weight: var(--body_typography-font-weight); letter-spacing: var(--body_typography-letter-spacing); text-align: var(--awb-content-alignment); text-transform: var(--awb-text-transform); background-color: rgba(255, 255, 255, 0);" href="https://www.fda.gov/food/food-labeling-nutrition/food-allergies" target="_blank" rel="noopener noreferrer">FDA: Food Allergies <a style="font-family: var(--body_typography-font-family); font-size: var(--body_typography-font-size); font-style: var(--body_typography-font-style,normal); font-weight: var(--body_typography-font-weight); letter-spacing: var(--body_typography-letter-spacing); text-align: var(--awb-content-alignment); text-transform: var(--awb-text-transform); background-color: rgba(255, 255, 255, 0);" href="https://www.worldallergyorganizationjournal.org/action/showPdf?pii=S1939-4551%2822%2900063-1" target="_blank" rel="noopener noreferrer">Managing food allergy: GA2LEN guideline 2022 [/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container][fusion_builder_container type="flex" hundred_percent="no" equal_height_columns="no" hide_on_mobile="small-visibility,medium-visibility,large-visibility" background_position="center center" background_repeat="no-repeat" fade="no" background_parallax="none" parallax_speed="0.3" video_aspect_ratio="16:9" video_loop="yes" video_mute="yes" border_style="solid"][fusion_builder_row][fusion_builder_column type="1_1" type="1_1" layout="1_1" background_position="left top" border_style="solid" border_position="all" spacing="yes" background_repeat="no-repeat" margin_top="0px" margin_bottom="0px" animation_speed="0.3" animation_direction="left" hide_on_mobile="small-visibility,medium-visibility,large-visibility" center_content="no" last="true" hover_type="none" background_blend_mode="overlay" first="true" min_height="" link=""][fusion_text] Asthma Dupilumab Prescribing Information Tezepelumab Prescribing Information Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma 2022 GINA Pocket Guide for Asthma Management and Prevention (for Adults and Children Older Than 5 Years) 2022 GINA Main Report: Global Strategy for Asthma Management and Prevention American Lung Association: Severe Asthma Advances and recent developments in asthma in 2020 Asthma biologics: Comparing trial designs, patient cohorts and study results Mepolizumab Prescribing Information National Jewish Health Inhaler Instructional Videos Chronic Spontaneous Urticaria (CSU) Urticaria Voices: Real-World Experience of Patients Living with Chronic Spontaneous Urticaria Chronic Spontaneous Urticaria: A Review Update on the Treatment of Chronic Spontaneous Urticaria Endotypes, phenotypes, and biomarkers in chronic spontaneous urticaria: Evolving toward personalized medicine Chronic Spontaneous Urticaria: Current and Emerging Biologic Agents Dupilumab Improves Itch And Urticaria Activity In Patients With Chronic Spontaneous Urticaria: Pooled Results From Two Phase 3 Trials (LIBERTY-CSU CUPID Study A and Study C) Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials Remibrutinib in Chronic Spontaneous Urticaria Remibrutinib demonstrates favorable safety profile and sustained efficacy in chronic spontaneous urticaria over 52 weeks Current and Emerging Therapies for Chronic Spontaneous Urticaria: A Narrative Review Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances Remibrutinib demonstrates favorable safety profile and sustained efficacy in chronic spontaneous urticaria over 52 weeks Urticaria Omalizumab Re-Treatment and Step-Up in Patients with Chronic Spontaneous Urticaria: OPTIMA Trial <a style="background-color: rgba(255, 255, 255, 0); font-family: var(--body_typography-font-family); font-size: var(--body_typography-font-size); font-style: var(--body_typography-font-style,normal); font-weight: var(--body_typography-font-weight); letter-spacing: var(--body_typography-letter-spacing);" href="https://www.sciencedirect.com/science/article/abs/pii/S1081120622012194" target="_blank" rel="noopener noreferrer">Dupilumab Efficacy In Patients With Chronic Spontaneous Urticaria By Ige Level: Liberty-CSU Cupid Study A Novel biologics for treatment of chronic spontaneous urticaria <a style="background-color: rgba(255, 255, 255, 0); font-family: var(--body_typography-font-family); font-size: var(--body_typography-font-size); font-style: var(--body_typography-font-style,normal); font-weight: var(--body_typography-font-weight); letter-spacing: var(--body_typography-letter-spacing);" href="https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.13005" target="_blank" rel="noopener noreferrer">Remibrutinib (LOU064): A selective potent oral BTK inhibitor with promising clinical safety and pharmacodynamics in a randomized phase I trial <a style="background-color: rgba(255, 255, 255, 0); font-family: var(--body_typography-font-family); font-size: var(--body_typography-font-size); font-style: var(--body_typography-font-style,normal); font-weight: var(--body_typography-font-weight); letter-spacing: var(--body_typography-letter-spacing);" href="https://www.nature.com/articles/s41591-021-01537-w" target="_blank" rel="noopener noreferrer">Fenebrutinib in H1 antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial <a style="background-color: rgba(255, 255, 255, 0); font-family: var(--body_typography-font-family); font-size: var(--body_typography-font-size); font-style: var(--body_typography-font-style,normal); font-weight: var(--body_typography-font-weight); letter-spacing: var(--body_typography-letter-spacing);" href="https://e-aair.org/DOIx.php?id=10.4168/aair.2021.13.2.206" target="_blank" rel="noopener noreferrer">Total IgE as a Marker for Chronic Spontaneous Urticaria <a style="background-color: rgba(255, 255, 255, 0); font-family: var(--body_typography-font-family); font-size: var(--body_typography-font-size); font-style: var(--body_typography-font-style,normal); font-weight: var(--body_typography-font-weight); letter-spacing: var(--body_typography-letter-spacing);" href="https://onlinelibrary.wiley.com/doi/epdf/10.1111/all.15603" target="_blank" rel="noopener noreferrer">Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances <a style="background-color: rgba(255, 255, 255, 0); font-family: var(--body_typography-font-family); font-size: var(--body_typography-font-size); font-style: var(--body_typography-font-style,normal); font-weight: var(--body_typography-font-weight); letter-spacing: var(--body_typography-letter-spacing);" href="https://onlinelibrary.wiley.com/doi/epdf/10.1111/all.15090" target="_blank" rel="noopener noreferrer">The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria <a style="background-color: rgba(255, 255, 255, 0); font-family: var(--body_typography-font-family); font-size: var(--body_typography-font-size); font-style: var(--body_typography-font-style,normal); font-weight: var(--body_typography-font-weight); letter-spacing: var(--body_typography-letter-spacing);" href="https://www.uptodate.com/contents/hives-urticaria-beyond-the-basics" target="_blank" rel="noopener noreferrer">Patient education: Hives (urticaria) (Beyond the Basics) [/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]

Allergy & Immunology - Vindico Medical Education

Food Allergies

Asthma

Chronic Spontaneous Urticaria (CSU)

Urticaria Voices: Real-World Experience of Patients Living with Chronic Spontaneous Urticaria
Chronic Spontaneous Urticaria: A Review
Update on the Treatment of Chronic Spontaneous Urticaria
Endotypes, phenotypes, and biomarkers in chronic spontaneous urticaria: Evolving toward personalized medicine
Chronic Spontaneous Urticaria: Current and Emerging Biologic Agents
Dupilumab Improves Itch And Urticaria Activity In Patients With Chronic Spontaneous Urticaria: Pooled Results From Two Phase 3 Trials (LIBERTY-CSU CUPID Study A and Study C)
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials
Remibrutinib in Chronic Spontaneous Urticaria
Remibrutinib demonstrates favorable safety profile and sustained efficacy in chronic spontaneous urticaria over 52 weeks
Current and Emerging Therapies for Chronic Spontaneous Urticaria: A Narrative Review
Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances
Remibrutinib demonstrates favorable safety profile and sustained efficacy in chronic spontaneous urticaria over 52 weeks
Urticaria
Omalizumab Re-Treatment and Step-Up in Patients with Chronic Spontaneous Urticaria: OPTIMA Trial
Dupilumab Efficacy In Patients With Chronic Spontaneous Urticaria By Ige Level: Liberty-CSU Cupid Study A
Novel biologics for treatment of chronic spontaneous urticaria
Remibrutinib (LOU064): A selective potent oral BTK inhibitor with promising clinical safety and pharmacodynamics in a randomized phase I trial
Fenebrutinib in H1 antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial
Total IgE as a Marker for Chronic Spontaneous Urticaria
Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Patient education: Hives (urticaria) (Beyond the Basics)